[VRTX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
02-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -14.54%
YoY- -8.17%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 2,517,700 2,483,500 2,493,200 2,374,800 2,302,700 2,334,300 2,196,200 9.50%
PBT 1,147,600 1,179,200 1,161,500 891,500 1,076,800 1,176,400 1,024,400 7.84%
Tax 178,800 143,900 245,800 191,700 257,900 245,900 213,900 -11.23%
NP 968,800 1,035,300 915,700 699,800 818,900 930,500 810,500 12.59%
Tax Rate -15.58% -12.20% -21.16% -21.50% -23.95% -20.90% -20.88% -
Total Cost 1,548,900 1,448,200 1,577,500 1,675,000 1,483,800 1,403,800 1,385,700 7.68%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 38.48 41.69 36.73 29.47 35.56 39.86 36.90 2.82%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 3.76 4.01 3.55 2.72 3.19 3.63 3.17 12.01%
EPS Diluted 3.71 3.97 3.52 2.69 3.15 3.59 3.13 11.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.